Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Milo Gatti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Ceftazidime, Azabicyclo Compounds, Liver Transplantation, Anti-Bacterial Agents. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Objectives
To assess the biliary pharmacokinetic/pharmacodynamic (PK/PD) of continuous infusion (CI) ceftazidime–avibactam in a series of critical orthotopic liver transplant (OLT) recipients having pre-emptive therapy during OLT because of carbapenemase-producing Enterobacterales (CPE) rectal colonization or targeted therapy of CPE intra-abdominal (IAIs) and/or biliary tract infections (BTIs).
Methods
We performed an exploratory, hypothesis-generating prospective case series including critical OLT recipients carrying a Kehr’s tube and undergoing therapeutic drug monitoring of ceftazidime and avibactam in both bile and plasma simultaneously while receiving CI ceftazidime–avibactam pre-emptive or targeted therapy. Biliary aggressive joint PK/PD target attainment [defined as a free ceftazidime steady-state concentrations fCss/MIC ratio >4 coupled with an avibactam fCss/target concentration (CT = 4 mg/L) ratio >1] was selected as optimal threshold of ceftazidime–avibactam efficacy, given this was previously shown to be independently associated with lower rates of microbiological failure and resistance development. Bile-to-plasma fCss ratios were calculated.
Results
Overall, four critical OLT recipients were included. Aggressive biliary ceftazidime–avibactam joint PK/PD target during treatment with CI 2 g/0.5 g q8 h over 8 h was attained in 2/4 cases (quasi-optimal and suboptimal in one case each). Median (range) fCss bile-to-plasma ratios were 0.28 (0.22–0.38) for ceftazidime and 0.24 (0.11–0.52) for avibactam.
Conclusions
Our limited cases series suggested that both ceftazidime and avibactam showed a moderate and broadly similar biliary penetration. Administration by CI may be helpful in attaining an aggressive biliary joint PK/PD target of ceftazidime–avibactam against pathogens with an MIC up to 8 mg/L.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
- Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Infectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Division of Anesthesiology, Department of Anesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Operative Unit of Microbiology, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Matteo Rinaldi, Federico Pea
Förderung
- Italian Ministry of Health
Zitieren
APA
Gatti, M., Rinaldi, M., Laici, C., Ambretti, S., Siniscalchi, A., Viale, P., & Pea, F. (2026). Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag009
Vancouver
Gatti M, Rinaldi M, Laici C, Ambretti S, Siniscalchi A, Viale P, et al. Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag009
BibTeX
@article{Gatti2026,
author = {Gatti, Milo and Rinaldi, Matteo and Laici, Cristiana and Ambretti, Simone and Siniscalchi, Antonio and Viale, Pierluigi and Pea, Federico},
title = {Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag009}
}
EUVIMED